Apogee Therapeutics

Updated: March 19, 2026
CEO Michael Henderson
CEO Michael Henderson
Country: USA | Funding: $997M (+)
Founded: 2022

Website: http://www.apogeetherapeutics.com/

Apogee Therapeutics operates pipeline candidates designed to treat inflammatory and immunological disorders.

Competitors